Dynatronics Corporation (DYNT)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 32.53 Million USD | -19.88% |
| 2023 | 40.6 Million USD | -8.41% |
| 2022 | 44.33 Million USD | -7.24% |
| 2021 | 47.79 Million USD | -10.5% |
| 2020 | 53.4 Million USD | -14.63% |
| 2019 | 62.56 Million USD | -2.87% |
| 2018 | 64.41 Million USD | 80.14% |
| 2017 | 35.75 Million USD | 17.58% |
| 2016 | 30.41 Million USD | 4.44% |
| 2015 | 29.11 Million USD | 6.1% |
| 2014 | 27.44 Million USD | -7.09% |
| 2013 | 29.53 Million USD | -6.71% |
| 2012 | 31.66 Million USD | -3.15% |
| 2011 | 32.69 Million USD | -0.82% |
| 2010 | 32.96 Million USD | 1.71% |
| 2009 | 32.4 Million USD | -0.57% |
| 2008 | 32.59 Million USD | 82.72% |
| 2007 | 17.83 Million USD | -8.59% |
| 2006 | 19.51 Million USD | -4.37% |
| 2005 | 20.4 Million USD | -0.89% |
| 2004 | 20.58 Million USD | 21.84% |
| 2003 | 16.89 Million USD | 3.43% |
| 2002 | 16.33 Million USD | -2.51% |
| 2001 | 16.75 Million USD | 10.44% |
| 2000 | 15.17 Million USD | -5.17% |
| 1999 | 16 Million USD | 30.08% |
| 1998 | 12.3 Million USD | 20.59% |
| 1997 | 10.2 Million USD | 50.0% |
| 1996 | 6.8 Million USD | 11.48% |
| 1995 | 6.1 Million USD | 24.49% |
| 1994 | 4.9 Million USD | -18.33% |
| 1993 | 6 Million USD | -9.09% |
| 1992 | 6.6 Million USD | 4.76% |
| 1991 | 6.3 Million USD | -4.55% |
| 1990 | 6.6 Million USD | -10.81% |
| 1989 | 7.4 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 9.35 Million USD | 10.83% |
| 2024 Q3 | 7.65 Million USD | -6.05% |
| 2024 Q4 | 7.37 Million USD | -3.72% |
| 2024 Q2 | 8.15 Million USD | -12.84% |
| 2023 Q1 | 12.05 Million USD | 7.7% |
| 2023 FY | 40.6 Million USD | -8.41% |
| 2023 Q2 | 10.88 Million USD | -9.71% |
| 2023 Q3 | 9.23 Million USD | -15.14% |
| 2023 Q4 | 8.43 Million USD | -8.63% |
| 2022 FY | 44.33 Million USD | -7.24% |
| 2022 Q1 | 12.3 Million USD | 0.51% |
| 2022 Q2 | 10.52 Million USD | -14.4% |
| 2022 Q3 | 10.31 Million USD | -2.03% |
| 2022 Q4 | 11.19 Million USD | 8.48% |
| 2021 FY | 47.79 Million USD | -10.5% |
| 2021 Q1 | 12.13 Million USD | 49.49% |
| 2021 Q2 | 11.96 Million USD | -1.36% |
| 2021 Q3 | 11.46 Million USD | -4.24% |
| 2021 Q4 | 12.23 Million USD | 6.78% |
| 2020 Q3 | 13.7 Million USD | -9.81% |
| 2020 Q1 | 16.38 Million USD | 5.68% |
| 2020 Q2 | 15.19 Million USD | -7.28% |
| 2020 FY | 53.4 Million USD | -14.63% |
| 2020 Q4 | 8.11 Million USD | -40.79% |
| 2019 Q3 | 14.55 Million USD | -5.75% |
| 2019 Q4 | 15.5 Million USD | 6.57% |
| 2019 FY | 62.56 Million USD | -2.87% |
| 2019 Q1 | 17.06 Million USD | 0.97% |
| 2019 Q2 | 15.43 Million USD | -9.53% |
| 2018 Q3 | 16.63 Million USD | -8.0% |
| 2018 Q4 | 16.9 Million USD | 1.61% |
| 2018 FY | 64.41 Million USD | 80.14% |
| 2018 Q1 | 12.79 Million USD | 14.61% |
| 2018 Q2 | 18.08 Million USD | 41.28% |
| 2017 FY | 35.75 Million USD | 17.58% |
| 2017 Q4 | 11.16 Million USD | 44.72% |
| 2017 Q3 | 7.71 Million USD | -11.45% |
| 2017 Q1 | 8.16 Million USD | 0.39% |
| 2017 Q2 | 8.71 Million USD | 6.75% |
| 2016 FY | 30.41 Million USD | 4.44% |
| 2016 Q4 | 8.13 Million USD | 9.74% |
| 2016 Q3 | 7.4 Million USD | -0.88% |
| 2016 Q2 | 7.47 Million USD | 1.05% |
| 2016 Q1 | 7.39 Million USD | -6.45% |
| 2015 Q3 | 6.69 Million USD | -8.39% |
| 2015 FY | 29.11 Million USD | 6.1% |
| 2015 Q1 | 7.21 Million USD | 2.27% |
| 2015 Q2 | 7.3 Million USD | 1.2% |
| 2015 Q4 | 7.9 Million USD | 18.18% |
| 2014 Q3 | 6.18 Million USD | -13.45% |
| 2014 FY | 27.44 Million USD | -7.09% |
| 2014 Q4 | 7.05 Million USD | 14.08% |
| 2014 Q1 | 7.05 Million USD | -2.87% |
| 2014 Q2 | 7.14 Million USD | 1.29% |
| 2013 FY | 29.53 Million USD | -6.71% |
| 2013 Q4 | 7.26 Million USD | 2.73% |
| 2013 Q3 | 7.07 Million USD | -11.6% |
| 2013 Q2 | 7.99 Million USD | 10.99% |
| 2013 Q1 | 7.2 Million USD | -6.88% |
| 2012 Q3 | 7.65 Million USD | -7.51% |
| 2012 Q4 | 7.73 Million USD | 1.11% |
| 2012 FY | 31.66 Million USD | -3.15% |
| 2012 Q1 | 7.99 Million USD | -2.36% |
| 2012 Q2 | 8.27 Million USD | 3.48% |
| 2011 Q1 | 7.91 Million USD | -0.3% |
| 2011 Q2 | 8.19 Million USD | 3.54% |
| 2011 Q4 | 8.19 Million USD | -2.31% |
| 2011 Q3 | 8.38 Million USD | 2.25% |
| 2011 FY | 32.69 Million USD | -0.82% |
| 2010 Q1 | 8.28 Million USD | 2.78% |
| 2010 Q3 | 8.23 Million USD | -3.13% |
| 2010 Q4 | 7.94 Million USD | -3.54% |
| 2010 Q2 | 8.5 Million USD | 2.64% |
| 2010 FY | 32.96 Million USD | 1.71% |
| 2009 Q3 | 7.63 Million USD | -12.45% |
| 2009 Q1 | 7.99 Million USD | -0.76% |
| 2009 Q2 | 8.71 Million USD | 9.04% |
| 2009 FY | 32.4 Million USD | -0.57% |
| 2009 Q4 | 8.05 Million USD | 5.57% |
| 2008 Q1 | 7.89 Million USD | 59.76% |
| 2008 Q2 | 8.86 Million USD | 12.29% |
| 2008 Q3 | 7.78 Million USD | -12.18% |
| 2008 Q4 | 8.05 Million USD | 3.54% |
| 2008 FY | 32.59 Million USD | 82.72% |
| 2007 FY | 17.83 Million USD | -8.59% |
| 2007 Q3 | 4.33 Million USD | -2.21% |
| 2007 Q1 | 4.13 Million USD | -16.28% |
| 2007 Q2 | 4.42 Million USD | 6.99% |
| 2007 Q4 | 4.93 Million USD | 14.06% |
| 2006 FY | 19.51 Million USD | -4.37% |
| 2006 Q4 | 4.94 Million USD | -0.71% |
| 2006 Q3 | 4.97 Million USD | -4.8% |
| 2006 Q2 | 5.23 Million USD | 20.02% |
| 2006 Q1 | 4.35 Million USD | -14.79% |
| 2005 Q4 | 5.11 Million USD | 1.32% |
| 2005 Q3 | 5.04 Million USD | -5.16% |
| 2005 FY | 20.4 Million USD | -0.89% |
| 2005 Q1 | 4.91 Million USD | -2.1% |
| 2005 Q2 | 5.32 Million USD | 8.21% |
| 2004 Q4 | 5.02 Million USD | -4.23% |
| 2004 Q2 | 5.28 Million USD | 4.97% |
| 2004 Q3 | 5.24 Million USD | -0.71% |
| 2004 FY | 20.58 Million USD | 21.84% |
| 2004 Q1 | 5.03 Million USD | 12.03% |
| 2003 FY | 16.89 Million USD | 3.43% |
| 2003 Q2 | 4.12 Million USD | 0.23% |
| 2003 Q1 | 4.11 Million USD | 1.51% |
| 2003 Q4 | 4.49 Million USD | 7.92% |
| 2003 Q3 | 4.16 Million USD | 0.93% |
| 2002 Q3 | 4.15 Million USD | 5.13% |
| 2002 FY | 16.33 Million USD | -2.51% |
| 2002 Q4 | 4.05 Million USD | -2.52% |
| 2002 Q2 | 3.95 Million USD | -5.06% |
| 2002 Q1 | 4.16 Million USD | -1.39% |
| 2001 Q2 | 4.04 Million USD | -0.47% |
| 2001 Q3 | 4.41 Million USD | 9.14% |
| 2001 Q4 | 4.22 Million USD | -4.34% |
| 2001 FY | 16.75 Million USD | 10.44% |
| 2001 Q1 | 4.06 Million USD | -10.11% |
| 2000 Q2 | 3.4 Million USD | -2.86% |
| 2000 Q3 | 3.75 Million USD | 10.49% |
| 2000 FY | 15.17 Million USD | -5.17% |
| 2000 Q1 | 3.5 Million USD | -5.41% |
| 2000 Q4 | 4.52 Million USD | 20.42% |
| 1999 Q2 | 4 Million USD | -18.37% |
| 1999 Q4 | 3.7 Million USD | 8.82% |
| 1999 FY | 16 Million USD | 30.08% |
| 1999 Q1 | 4.9 Million USD | 48.48% |
| 1999 Q3 | 3.4 Million USD | -15.0% |
| 1998 Q3 | 3 Million USD | 0.0% |
| 1998 FY | 12.3 Million USD | 20.59% |
| 1998 Q1 | 3 Million USD | 0.0% |
| 1998 Q2 | 3 Million USD | 0.0% |
| 1998 Q4 | 3.3 Million USD | 10.0% |
| 1997 Q4 | 3 Million USD | 20.0% |
| 1997 Q3 | 2.5 Million USD | 13.64% |
| 1997 Q1 | 2.4 Million USD | 33.33% |
| 1997 Q2 | 2.2 Million USD | -8.33% |
| 1997 FY | 10.2 Million USD | 50.0% |
| 1996 FY | 6.8 Million USD | 11.48% |
| 1996 Q4 | 1.8 Million USD | 12.5% |
| 1996 Q3 | 1.6 Million USD | -20.0% |
| 1996 Q2 | 2 Million USD | 53.85% |
| 1996 Q1 | 1.3 Million USD | -7.14% |
| 1995 FY | 6.1 Million USD | 24.49% |
| 1995 Q3 | 1.4 Million USD | -6.67% |
| 1995 Q2 | 1.5 Million USD | -16.67% |
| 1995 Q1 | 1.8 Million USD | 50.0% |
| 1995 Q4 | 1.4 Million USD | 0.0% |
| 1994 Q2 | 1.2 Million USD | 0.0% |
| 1994 Q1 | 1.2 Million USD | -29.41% |
| 1994 FY | 4.9 Million USD | -18.33% |
| 1994 Q4 | 1.2 Million USD | -7.69% |
| 1994 Q3 | 1.3 Million USD | 8.33% |
| 1993 Q4 | 1.7 Million USD | -10.53% |
| 1993 Q1 | 1.3 Million USD | -18.75% |
| 1993 FY | 6 Million USD | -9.09% |
| 1993 Q2 | 1.1 Million USD | -15.38% |
| 1993 Q3 | 1.9 Million USD | 72.73% |
| 1992 Q3 | 1.7 Million USD | 0.0% |
| 1992 Q2 | 1.7 Million USD | 13.33% |
| 1992 Q1 | 1.5 Million USD | -11.76% |
| 1992 Q4 | 1.6 Million USD | -5.88% |
| 1992 FY | 6.6 Million USD | 4.76% |
| 1991 Q2 | 1.4 Million USD | -12.5% |
| 1991 Q1 | 1.6 Million USD | 6.67% |
| 1991 Q4 | 1.7 Million USD | 0.0% |
| 1991 Q3 | 1.7 Million USD | 21.43% |
| 1991 FY | 6.3 Million USD | -4.55% |
| 1990 Q2 | 1.6 Million USD | 6.67% |
| 1990 Q4 | 1.5 Million USD | -16.67% |
| 1990 FY | 6.6 Million USD | -10.81% |
| 1990 Q1 | 1.5 Million USD | -25.0% |
| 1990 Q3 | 1.8 Million USD | 12.5% |
| 1989 Q1 | 1.5 Million USD | 0.0% |
| 1989 Q2 | 1.8 Million USD | 20.0% |
| 1989 FY | 7.4 Million USD | 0.0% |
| 1989 Q4 | 2 Million USD | -4.76% |
| 1989 Q3 | 2.1 Million USD | 16.67% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | -354.131% |
| Cerus Corporation | 156.36 Million USD | 79.194% |
| OrthoPediatrics Corp. | 148.73 Million USD | 78.126% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -3258.497% |
| Talis Biomedical Corporation | 412 Thousand USD | -7796.593% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -135.736% |
| Inogen, Inc. | 315.66 Million USD | 89.693% |
| Spectral AI, Inc. | 18.05 Million USD | -80.184% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -228.46% |
| CVRx, Inc. | 39.29 Million USD | 17.206% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -4951.858% |
| Orthofix Medical Inc. | 746.64 Million USD | 95.643% |
| Venus Concept Inc. | 76.35 Million USD | 57.391% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -169.79% |
| Bioventus Inc. | 512.34 Million USD | 93.65% |
| BrainsWay Ltd. | 31.78 Million USD | -2.356% |
| Envoy Medical, Inc. | 316 Thousand USD | -10195.559% |
| electroCore, Inc. | 16.03 Million USD | -102.957% |
| IceCure Medical Ltd | 3.22 Million USD | -907.555% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -1239.949% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -8813.439% |
| MaxCyte, Inc. | 41.28 Million USD | 21.202% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -1566.323% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -29276.571% |
| PAVmed Inc | 2.45 Million USD | -1226.834% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -44.473% |
| RxSight, Inc. | 89.07 Million USD | 63.477% |
| Sight Sciences, Inc. | 81.05 Million USD | 59.862% |
| SI-BONE, Inc. | 138.88 Million USD | 76.575% |
| TELA Bio, Inc. | 58.45 Million USD | 44.342% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -75.755% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 82.613% |
| LivaNova PLC | 1.15 Billion USD | 97.18% |
| 908 Devices Inc. | 50.22 Million USD | 35.229% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 93.254% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -42127.772% |
| NeuroPace, Inc. | 65.42 Million USD | 50.27% |
| LENSAR, Inc. | 42.16 Million USD | 22.839% |
| Apyx Medical Corporation | 52.34 Million USD | 37.852% |
| Cutera, Inc. | 212.36 Million USD | 84.68% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 2.47% |
| BioSig Technologies, Inc. | 18 Thousand USD | -180644.25% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 80.479% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -35.813% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 97.89% |
| Axonics, Inc. | 366.37 Million USD | 91.12% |
| Outset Medical, Inc. | 130.37 Million USD | 75.046% |
| IRIDEX Corporation | 51.86 Million USD | 37.277% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 76.112% |
| IRadimed Corporation | 65.56 Million USD | 50.377% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -2666.494% |
| INVO Bioscience, Inc. | 3.02 Million USD | -977.079% |
| Telesis Bio, Inc. | 27.5 Million USD | -18.267% |
| Viemed Healthcare, Inc. | 183 Million USD | 82.223% |
| Varex Imaging Corporation | 811 Million USD | 95.988% |
| Quipt Home Medical Corp. | 221.74 Million USD | 85.328% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 52.626% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -274.902% |
| Semler Scientific, Inc. | 68.18 Million USD | 52.285% |
| InMode Ltd. | 492.04 Million USD | 93.388% |
| Bruker Corporation | 2.96 Billion USD | 98.903% |
| Cytosorbents Corporation | 36.34 Million USD | 10.497% |
| DexCom, Inc. | 3.62 Billion USD | 99.102% |
| Align Technology, Inc. | 3.86 Billion USD | 99.158% |
| Viveve Medical, Inc. | 6.42 Million USD | -406.286% |
| ZimVie Inc. | 457.43 Million USD | 92.888% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 83.144% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -29276.571% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 95.649% |
| Profound Medical Corp. | 7.33 Million USD | -343.785% |
| Insulet Corporation | 1.69 Billion USD | 98.083% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 74.195% |
| iCAD, Inc. | 17.31 Million USD | -87.862% |
| Nuwellis, Inc. | 8.86 Million USD | -267.035% |
| Biotricity, Inc. | 12.06 Million USD | -169.693% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 93.397% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -424.319% |
| PAVmed Inc. | 2.45 Million USD | -1226.834% |
| BIOLASE, Inc. | 49.16 Million USD | 33.826% |
| Beyond Air, Inc. | 1.15 Million USD | -2707.072% |
| FONAR Corporation | 102.88 Million USD | 68.378% |
| AxoGen, Inc. | 159.01 Million USD | 79.54% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 88.145% |
| Inari Medical, Inc. | 493.63 Million USD | 93.409% |
| UFP Technologies, Inc. | 400.07 Million USD | 91.868% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -174813.79% |
| Tenon Medical, Inc. | 2.92 Million USD | -1011.133% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -377.595% |
| AdaptHealth Corp. | 3.2 Billion USD | 98.983% |
| Sintx Technologies, Inc. | 2.62 Million USD | -1138.446% |
| NanoVibronix, Inc. | 2.28 Million USD | -1325.053% |
| Quanterix Corporation | 122.36 Million USD | 73.413% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -33.309% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 83.775% |
| TransMedics Group, Inc. | 241.62 Million USD | 86.535% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -134.834% |
| NeuroMetrix, Inc. | 5.9 Million USD | -451.29% |
| Hyperfine, Inc. | 11.03 Million USD | -194.905% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 80.3% |
| Biomerica, Inc. | 5.41 Million USD | -500.812% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 35.654% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 81.633% |